Deal snapshot: Amgen Acquires Horizon Therapeutics for USD 27.8bn.

MANews-(C)2009-2023

US-based biotechnology company Amgen (NASDAQ: AMGN) has acquired Ireland-based biotechnology company Horizon Therapeutics plc for USD 116.50 per share in cash, representing a transaction equity value of...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT